FGP
ACHC icon

Freestone Grove Partners’s Acadia Healthcare ACHC Stock Holding History

Freestone Grove Partners’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
+636,116
New +$11.5M 0.11% 246
2025
Q1 		– Sell
-755,178
Closed -$29.9M – 572
2024
Q4 		$29.9M Buy
+755,178
New +$34.1M 0.37% 96

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Freestone Grove Partners's ACHC Position: Q1 2026 in Review

Freestone Grove Partners opened a new position in Acadia Healthcare (ACHC) in Q1 2026: 636,116 shares worth $14.9M. The stake represents 0.11% of the portfolio and ranks #246 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in ACHC as recently as Q4 2024.

Freestone Grove Partners first reported a position in ACHC in Q4 2024 and has held it in 2 quarters since. The position peaked at $29.9M in Q4 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Freestone Grove Partners held 636,116 shares of Acadia Healthcare worth $14.9M as of Q1 2026.
  • Acadia Healthcare was a new Freestone Grove Partners position in Q1 2026.
  • Acadia Healthcare made up 0.11% of Freestone Grove Partners's portfolio in Q1 2026, its #246 holding.
  • Freestone Grove Partners first reported a position in Acadia Healthcare in Q4 2024 and has held it in 2 quarters since.
  • Freestone Grove Partners's Acadia Healthcare position peaked at $29.9M in Q4 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.